Swiss National Bank Mirum Pharmaceuticals, Inc. Transaction History
Swiss National Bank
- $137 Billion
- Q1 2025
A detailed history of Swiss National Bank transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 69,800 shares of MIRM stock, worth $3.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,800
Previous 70,300
0.71%
Holding current value
$3.09 Million
Previous $2.91 Million
8.19%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MIRM
# of Institutions
224Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$301 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$211 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$143 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$124 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$113 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...